Affinity Chromatography Market Size to Hit USD 8.98 Billion by 2035

The global affinity chromatography market is witnessing strong growth, driven by rapid advancements in biopharmaceutical research and increasing demand for high-purity biomolecule separation techniques. The market size was valued at USD 3.90 billion in 2025 and is projected to grow from USD 4.24 billion in 2026 to approximately USD 8.98 billion by 2035, expanding at a CAGR of 8.70% during the forecast period.

Read Also: Desalting Buffer Exchange Market

Affinity chromatography is a highly specific purification technique used to isolate biomolecules such as proteins, antibodies, enzymes, and nucleic acids based on selective biological interactions. Its precision, scalability, and efficiency make it an essential component in drug development, diagnostics, and bioprocessing industries.

The rising prevalence of chronic diseases, increasing biologics production, and growing adoption of monoclonal antibody therapies are significantly contributing to market expansion.

Key Market Highlights

• North America dominated the market with a 38% share in 2025
• Asia Pacific is expected to grow at the fastest CAGR through 2035
• Resins segment led the market with a 58% share in 2025
• Protein A affinity chromatography dominated techniques with 48% share
• Antibody purification remained the top application segment
• Pharmaceutical & biotechnology companies accounted for 60% market share

Market Trends

Rising Demand for Advanced Affinity Techniques

The growing use of Protein A/G/L chromatography and IMAC (Immobilized Metal Affinity Chromatography) is expanding beyond drug manufacturing into diagnostics, including rapid test kits.

Surge in Biologics and Vaccine Production

The increasing production of monoclonal antibodies, recombinant proteins, and vaccines is fueling demand for highly specific purification methods like affinity chromatography.

Technological Advancements in Resins and Ligands

Innovations in resin design and ligand chemistry are improving binding capacity, process efficiency, and cost-effectiveness.

Shift Toward Disposable Systems

Single-use chromatography columns are gaining traction due to their ability to minimize contamination risks and eliminate cleaning validation processes.

Expansion in Emerging Markets

Growing healthcare infrastructure and increased investment in biotechnology R&D in emerging economies are creating lucrative opportunities.

Market Dynamics

Driver: Growing Demand for Biopharmaceuticals

The increasing pipeline of biologics, especially monoclonal antibodies and recombinant proteins, is a major driver. These biologics require high-purity separation processes, boosting the demand for affinity chromatography.

Restraint: Regulatory Complexity

Stringent regulatory requirements and complex validation processes pose challenges. Additionally, the need for skilled professionals and high operational costs may limit adoption.

Opportunity: Automation and Process Optimization

Automation technologies are transforming chromatography workflows by improving reproducibility, reducing manual intervention, and enhancing productivity in GMP environments.

Segment Insights

Product Insights

The resins segment dominated the market with a 58% share in 2025, owing to their high binding capacity, specificity, and scalability in purifying complex biologics. Agarose-based resins are widely used in downstream processing, particularly for monoclonal antibody purification.

The columns segment, accounting for 22% share, is gaining traction due to its reproducibility and compatibility with automated systems. These systems support high-throughput processing and are essential in large-scale manufacturing.

The kits & reagents segment is expected to grow at the fastest rate, driven by increasing demand for ready-to-use solutions in research and drug development.

Application Insights

The antibody purification segment held the largest market share in 2025. Affinity chromatography enables high selectivity and purity in a single step, making it ideal for monoclonal antibody production.

The vaccine production segment is expected to witness the fastest growth due to the need for scalable and efficient purification processes during global health emergencies.

Other important applications include:

• Monoclonal antibodies
• Protein purification
• Diagnostics and biomarker discovery

Technique Insights

The Protein A affinity chromatography segment led the market with a 48% share in 2025. It is considered the gold standard for monoclonal antibody purification due to its high specificity and efficiency.

The IMAC segment is the second-largest and is widely used for purifying recombinant proteins and metal-binding proteins.

Other techniques include:

• Dye-ligand chromatography (cost-effective alternative)
• Immunoaffinity chromatography (high specificity and purity)

End User Insights

The pharmaceutical & biotechnology companies segment dominated the market with a 60% share, driven by extensive R&D investments and large-scale biologics production.

The academic & research institutes segment holds the second-largest share, supported by growing research activities in genomics and proteomics.

The contract research organizations (CROs) segment is expected to grow at the fastest rate due to increasing outsourcing of drug development and purification processes.

Regional Insights

North America

North America led the global market with a 38% share in 2025, supported by:

• Advanced biopharmaceutical infrastructure
• High R&D investments
• Strong presence of biotech firms and CROs

The U.S. plays a crucial role, driven by continuous innovation in chromatography technologies and large-scale biologics manufacturing.

Asia Pacific

Asia Pacific is projected to grow at the fastest rate due to:

• Expanding biopharmaceutical manufacturing
• Government initiatives supporting biotech industries
• Increasing presence of CDMOs

Countries like China and India are investing heavily in biotechnology infrastructure, boosting regional demand.

Europe

Europe accounted for 29% market share in 2025, driven by:

• Strong pharmaceutical manufacturing base
• Strict regulatory standards
• High demand for biosimilars and biologics

Germany remains a key contributor due to its advanced research ecosystem and growing biotech startups.

Competitive Landscape

The affinity chromatography market is highly competitive, with major players focusing on innovation, product launches, and strategic collaborations. Key companies include:

• Cytiva
• Merck KGaA
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Sartorius AG
• Repligen Corporation
• Agilent Technologies
• PerkinElmer
• Shimadzu Corporation
• Avantor
• Pall Corporation

Recent Developments

• June 2025: A new high-capacity affinity resin was introduced to enhance antibody purification efficiency and reduce operational costs.
• May 2025: Advanced Protein A affinity columns with improved measurement accuracy were launched to support large molecule separations.

Market Segmentation

By Product

• Resins
• Columns
• Kits & Reagents

By Application

• Antibody Purification
• Protein Purification
• Vaccine Production
• Diagnostics

By Technique

• Protein A Affinity Chromatography
• IMAC
• Dye-Ligand Chromatography
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• CROs

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Conclusion

The affinity chromatography market is poised for substantial growth over the next decade, fueled by the rapid expansion of the biopharmaceutical sector and increasing demand for high-purity biomolecule separation technologies. Continuous advancements in chromatography techniques, automation, and resin technologies are expected to further enhance process efficiency and scalability.

With growing investments in biotechnology and increasing adoption of biologics, the market is set to play a critical role in shaping the future of drug development and precision medicine.

Get Sample: https://www.precedenceresearch.com/sample/8277